Bolder BioPATH, Inc. is a contract pharmacology, toxicology and pathology company specializing in In Vivo models of rheumatoid arthritis, osteoarthritis and cancer as well as other autoimmune and inflammation models, Our goals are to provide preclinical (efficacy and toxicity) data to support advancing proteins and small molecules to IND/NDA stage.